StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.
StemSight has raised $2.4M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
StemSight's investors include Voima Ventures, Business Finland, Stephen Industries, Avohoidon Tutkimusstio, Biothom Oy.
StemSight is headquartered in Tampere, Finland.
StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.
StemSight is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"StemSight — Funding & Investors." VCBacked, February 13, 2025, https://www.vcbacked.co/company/stemsight. Accessed October 27, 2026.
VCBacked. (2025). StemSight — Funding & Investors. Retrieved October 27, 2026, from https://www.vcbacked.co/company/stemsight
{{cite web |title=StemSight — Funding & Investors |url=https://www.vcbacked.co/company/stemsight |website=VCBacked |access-date=October 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated